Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Sponsored Links
Bristol-Myers starts tender offer for Amylin
(Reuters) - Bristol-Myers Squibb Co on Tuesday launched its tender offer to buy all outstanding shares of biotechnology company Amylin Pharmaceuticals Inc.
Bristol-Myers said last month it would pay $31 per share for Amylin, helping it extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon.
The offer to buy all of Amylin's common stock will expire at 5:00 p.m. New York time on August 7, unless extended, Bristol-Myers said in a statement.
(Reporting by Shailesh Kuber in Bangalore; Editing by Supriya Kurane)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters